Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis

October 2023 in “ Clinical, cosmetic and investigational dermatology ”

Chen Zhang, Tianlun Kang, Tangliang Qian, Mingyue Ma, Xiaofeng Hou, Chen Li

secukinumab alopecia areata tofacitinib palmoplantar pustulosis interleukin-17 biologics IL-17 AA PPP

TLDR Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A 35-year-old female patient with Palmoplantar Pustulosis (PPP) developed Alopecia Areata (AA), a rare side effect, after treatment with secukinumab, a drug that targets interleukin-17 (IL-17). After discontinuing secukinumab and starting treatment with tofacitinib, both her AA and PPP significantly improved. The study suggests that tofacitinib could be a potential treatment for AA induced by biologics during PPP treatment. However, more research with larger sample sizes is needed to confirm these findings.

View this study on dovepress.com →

Discuss this study in the Community →

Cited in this study

1 / 1 results

research Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata

222 citations , September 2016 in “JCI insight”

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

5 / 5 results

research Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth

November 2023 in “Cutis”

Tofacitinib helped a woman with total-body hair loss grow her hair back.

research Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis

1 citations , October 2023 in “Clinical, cosmetic and investigational dermatology”

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

research Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients

24 citations , January 2018 in “International Journal of Trichology”

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

research Brazilian Experience of Treating Alopecia Universalis with Novel Antirheumatic Therapy Tofacitinib: A Case Series

16 citations , July 2017 in “Rheumatology and Therapy”

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

research Excellent Response to Tofacitinib Treatment in a Patient with Alopecia Universalis

16 citations , January 2017 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)”

A patient with complete hair loss regrew all her hair using tofacitinib.